Cargando…

Historical trends and new surveillance of Plasmodium falciparum drug resistance markers in Angola

BACKGROUND: Plasmodium falciparum resistance to chloroquine (CQ) and sulfadoxine-pyrimethamine (SP) has historically posed a major threat to malaria control throughout the world. The country of Angola officially replaced CQ with artemisinin-based combination therapy (ACT) as a first-line treatment i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ebel, Emily R., Reis, Fátima, Petrov, Dmitri A., Beleza, Sandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028775/ https://www.ncbi.nlm.nih.gov/pubmed/33827587 http://dx.doi.org/10.1186/s12936-021-03713-2

Ejemplares similares

Plasmodium falciparum drug resistance in Angola
por: Fançony, Cláudia, et al.
Publicado: (2016)

Molecular markers of antifolate resistance in Plasmodium falciparum isolates from Luanda, Angola
por: Gama, Bianca E, et al.
Publicado: (2011)

Molecular epidemiology of drug-resistant Plasmodium falciparum in Benguela province, Angola
por: Foumane Ngane, Vincent, et al.
Publicado: (2015)

Pfkelch13 Plasmodium falciparum Mutations in Huambo, Angola
por: Rodrigues, Ana Beatriz Batista, et al.
Publicado: (2022)

Low-grade sulfadoxine–pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola
por: Kaingona-Daniel, Elsa P. S., et al.
Publicado: (2016)

Polymorphisms in Plasmodium falciparum K13-Propeller in Angola and Mozambique after the Introduction of the ACTs
por: Escobar, Carlos, et al.
Publicado: (2015)

Detection of atovaquone-proguanil resistance conferring mutations in Plasmodium falciparum cytochrome b gene in Luanda, Angola
por: Pimentel, Sónia, et al.
Publicado: (2006)

Artemether-lumefantrine treatment failure of uncomplicated Plasmodium falciparum malaria in travellers coming from Angola and Mozambique
por: Silva-Pinto, André, et al.
Publicado: (2021)

Plasmodium falciparum isolates from Angola show the S(tct)VMNT haplotype in the pfcrt gene
por: Gama, Bianca E, et al.
Publicado: (2010)

Molecular Markers of Sulfadoxine-Pyrimethamine Resistance in Samples from Children with Uncomplicated Plasmodium falciparum at Three Sites in Angola in 2019
por: Rosillo, Stefano R., et al.
Publicado: (2023)

Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2015
por: Ljolje, Dragan, et al.
Publicado: (2018)

Molecular surveillance of putative drug resistance markers of antifolate and artemisinin among imported Plasmodium falciparum in Qatar
por: Bansal, Devendra, et al.
Publicado: (2019)

Surveillance of molecular markers of antimalarial drug resistance in Plasmodium falciparum and Plasmodium vivax in Federally Administered Tribal Area (FATA), Pakistan
por: Nadeem, Muhammad Faisal, et al.
Publicado: (2021)

Whole genomes from Angola and Mozambique inform about the origins and dispersals of major African migrations
por: Tallman, Sam, et al.
Publicado: (2023)

Establishing a National Molecular Surveillance Program for the Detection of Plasmodium falciparum Markers of Resistance to Antimalarial Drugs in Haiti
por: Hamre, Karen E. S., et al.
Publicado: (2020)

Biennial surveillance of Plasmodium falciparum anti-malarial drug resistance markers in Democratic Republic of Congo, 2017 and 2019
por: Yobi, Doudou M., et al.
Publicado: (2022)

Molecular surveillance of Plasmodium falciparum drug-resistance markers in Vietnam using multiplex amplicon sequencing (2000–2016)
por: Rovira-Vallbona, Eduard, et al.
Publicado: (2023)

Efficacy of artemether–lumefantrine, artesunate–amodiaquine, and dihydroartemisinin–piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015
por: Plucinski, Mateusz M., et al.
Publicado: (2017)

On the edge of Bantu expansions: mtDNA, Y chromosome and lactase persistence genetic variation in southwestern Angola
por: Coelho, Margarida, et al.
Publicado: (2009)

Molecular surveillance of drug resistance through imported isolates of Plasmodium falciparum in Europe
por: Jelinek, Tomas, et al.
Publicado: (2002)

Amplicon Sequencing as a Potential Surveillance Tool for Complexity of Infection and Drug Resistance Markers in Plasmodium falciparum Asymptomatic Infections( )
por: Wamae, Kevin, et al.
Publicado: (2022)

Whole-genome surveillance identifies markers of Plasmodium falciparum drug resistance and novel genomic regions under selection in Mozambique
por: Coonahan, Erin, et al.
Publicado: (2023)

Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal
por: Wurtz, Nathalie, et al.
Publicado: (2012)

A review of malaria molecular markers for drug resistance in Plasmodium falciparum and Plasmodium vivax in China
por: Wang, Siqi, et al.
Publicado: (2023)

Molecular Surveillance for Multidrug-Resistant Plasmodium falciparum, Cambodia
por: Shah, Naman K., et al.
Publicado: (2008)

Genetic surveillance for monitoring the impact of drug use on Plasmodium falciparum populations
por: Ndiaye, Yaye Die, et al.
Publicado: (2021)

Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania
por: Schönfeld, Mirjam, et al.
Publicado: (2007)

Drug resistance and vaccine target surveillance of Plasmodium falciparum using nanopore sequencing in Ghana
por: Girgis, Sophia T., et al.
Publicado: (2023)

Author Correction: Molecular surveillance of Plasmodium falciparum drug-resistance markers in Vietnam using multiplex amplicon sequencing (2000–2016)
por: Rovira-Vallbona, Eduard, et al.
Publicado: (2023)

Molecular epidemiology of drug resistance markers of Plasmodium falciparum in Yunnan Province, China
por: Huang, Fang, et al.
Publicado: (2012)

Temporal trends in molecular markers of drug resistance in Plasmodium falciparum in human blood and profiles of corresponding resistant markers in mosquito oocysts in Asembo, western Kenya
por: Zhou, Zhiyong, et al.
Publicado: (2022)

Molecular characterisation of drug-resistant Plasmodium falciparum from Thailand
por: Lopes, Dinora, et al.
Publicado: (2002)

High rate of adaptation of mammalian proteins that interact with Plasmodium and related parasites
por: Ebel, Emily R., et al.
Publicado: (2017)

Impacts of Antimalarial Drugs on Plasmodium falciparum Drug Resistance Markers, Western Kenya, 2003–2015
por: Hemming-Schroeder, Elizabeth, et al.
Publicado: (2018)

Drug resistance of Plasmodium falciparum and Plasmodium vivax isolates in Indonesia
por: Rahmasari, Farindira Vesti, et al.
Publicado: (2022)

Molecular surveillance of anti-malarial drug resistance genes in Plasmodium falciparum isolates in Odisha, India
por: Rana, Ramakanta, et al.
Publicado: (2022)

Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal
por: Ranjitkar, Samir, et al.
Publicado: (2011)

Molecular Profiles of Multiple Antimalarial Drug Resistance Markers in Plasmodium falciparum and Plasmodium vivax in the Mandalay Region, Myanmar
por: Lê, Hương Giang, et al.
Publicado: (2022)

Efficacy and safety of artemether–lumefantrine, artesunate–amodiaquine, and dihydroartemisinin–piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017
por: Davlantes, Elizabeth, et al.
Publicado: (2018)

Epidemiology of Plasmodium falciparum infection and drug resistance markers in Ota Area, Southwestern Nigeria
por: Olasehinde, GI, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jd9s57cdl9vgup9ch5ciqji8v7